Psilocybin's effects on anhedonia

2024-519265-22-00 Human pharmacology (Phase I) - Other Ongoing, recruiting

Start 12 Nov 2025 · Status Ongoing, recruiting · 1 EU/EEA countries · 1 sites

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - Other
Status Ongoing, recruiting
Participants planned 65
Countries 1
Sites 1

Major Depressive Disorder

Key facts

Sponsor
Medical University Of Vienna
Participant type
Healthy volunteers, Patients
Age range
18-64 years
Gender
Male and Female
Therapeutic area
Psychiatry and Psychology [F] - Mental Disorders [F03], Psychiatry and Psychology [F] - Psychological Phenomena [F02], Psychiatry and Psychology [F] - Behavior and Behavior Mechanisms [F01]
Trial duration
12 Nov 2025 → ongoing
Decision date (initial)
2025-04-14
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Major Depressive Disorder

VersionLevelCodeTermSystem organ class
21.1 PT 10054976 Antidepressant therapy 100000004865
24.0 LLT 10056941 MRI brain 10022891
20.0 LLT 10027942 Mood depression 10037175
23.0 LLT 10083288 Clinical depression 10037175
20.0 PT 10002511 Anhedonia 100000004873

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Medical University Of Vienna

Sponsor organisation
Medical University Of Vienna
Address
Spitalgasse 23, Alsergrund Alsergrund
City
Vienna
Postcode
1090
Country
Austria

Scientific contact point

Organisation
Medical University Of Vienna
Contact name
Department of Psychiatry and Psychotherapy, Division of General Psychiatry

Public contact point

Organisation
Medical University Of Vienna
Contact name
Department of Psychiatry and Psychotherapy, Division of General Psychiatry

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
Austria Ongoing, recruiting 65 1
Rest of world 0

Investigational sites

Austria

1 site · Ongoing, recruiting
Medical University Of Vienna
Department of Psychiatry and Psychotherapy, Division of General Psychiatry, Waehringer Guertel 18-20, Alsergrund, Vienna

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Austria 2025-11-12 2025-11-12

Application history

4 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-12-03 Austria Acceptable
2025-04-07
2025-04-14
2 NON SUBSTANTIAL MODIFICATION NSM-1 2025-09-10 Austria Acceptable
2025-04-07
2025-09-10
3 SUBSTANTIAL MODIFICATION SM-1 2026-02-09 Austria Acceptable
2026-04-07
2026-04-12
4 NON SUBSTANTIAL MODIFICATION NSM-2 2026-05-27 Austria Acceptable
2026-04-07
2026-05-27